Form 4: Waters Corp Director Acquires Shares, Options

Waters Corp Director Heather Knight acquired 23 shares of common stock and 57 stock options, with both vesting in February 2027.

Summary

• Heather Knight, a Director of Waters Corp, acquired 23 shares of common stock on February 25, 2026.
• These acquired shares are restricted and will vest 100% on February 9, 2027.
• Knight also acquired 57 stock options on February 25, 2026, with an exercise price of $319.44.
• The stock options will vest and become exercisable on February 9, 2027, and are set to expire on February 25, 2036.
• Following these transactions, Knight directly beneficially owns 1,149.07 shares of common stock and 57 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates a director's continued commitment and increased stake in the company, aligning their interests with long-term shareholder value.

Positives

• Director Heather Knight increased her direct beneficial ownership in Waters Corp by acquiring additional common stock and stock options.
• The acquisition of restricted stock and stock options aligns the director's interests with long-term shareholder value through future vesting.

Future Outlook

The acquired restricted stock and stock options are scheduled to vest on February 9, 2027, indicating a future alignment of the director's compensation with the company's performance over the coming year.

Industry Context

StockSavvy.ai notes that insider acquisitions, particularly of restricted stock and options, are a common component of executive and director compensation packages in the life sciences and analytical instruments industry. These grants are designed to incentivize long-term performance and align the interests of company leadership with shareholders, a practice consistent across peers like Agilent Technologies (A) and Thermo Fisher Scientific (TMO).

Comparison to Industry Standards

• The grant of restricted stock and stock options to a director is a standard practice in corporate governance for publicly traded companies, including those in the specialized analytical instruments sector.
• The vesting schedule, with a full vest on February 9, 2027, is typical for annual equity grants, similar to practices observed at companies like Danaher Corporation (DHR) or PerkinElmer (PKI) for their non-employee directors.
• The exercise price of $319.44 for the options would typically be the closing price of Waters Corp stock on the grant date, a common benchmark for option grants across the industry.

Stakeholder Impact

• Shareholders: The director's increased ownership stake may be viewed positively, signaling confidence in the company's future performance.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• The acquired restricted shares and stock options will vest on February 9, 2027.
• The stock options will become exercisable on February 9, 2027, and expire on February 25, 2036.

Key Dates

Recommendation

The filing reports a routine grant of restricted stock and stock options to a director as part of their compensation. While it signals continued alignment of interests between the director and shareholders, it does not present new information significant enough to alter a fundamental investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Waters Corp, WAT, Insider Transaction, Form 4, Stock Option, Restricted Stock, Director Compensation, Heather Knight